Xtalks — The Life Science Community™, Online webinar
2026-10-15
In dermatology clinical trials, seeing change and proving clinically meaningful change are not the same thing. Disease can fluctuate between visits, severity can vary across body regions and patients and clinician assessments and patient-reported symptoms may capture different components of the treatment story. Without adequate controls, this variability can make meaningful treatment effects harder to detect and interpret. Building confidence in the evidence requires an endpoint strategy that accounts for each step in the assessment workflow that may introduce variability or bias. This webinar explores how an integrated endpoint strategy can help control these sources of variability and strengthen confidence in dermatology trial evidence. Bringing these measures together can provide a more complete picture of efficacy, patient experience and safety. Standardized image capture and centralized imaging workflows can reduce variability in longitudinal visual assessments and provide a method to appropriately document flares or safety events without imparting significant burden to site personnel or patients. Consistent clinician-reported outcome (ClinRO) implementation and robust rater training can strengthen scoring reliability, while well-designed electronic clinical outcome assessment (eCOA) strategies can capture the day-to-day patient experience beyond site visits. This webinar brings together experts in medical imaging, eCOA and cardiac safety to explore how these complementary approaches can strengthen endpoint quality in dermatology trials. The speakers will discuss strategies for improving image consistency, reducing inter- and intra-rater variability, capturing meaningful symptom data and addressing factors that may contribute to placebo response. They will also examine what cardiac safety assessments may be required and how ECG strategies can be incorporated efficiently. Register to learn how dermatology clinical trials can benefit from a more integrated endpoint strategy that reduces variability, strengthens confidence in treatment-effect data and generates a more complete body of evidence across efficacy, patient experience and safety.
|